Evidence map›Paper›PMID 29288359›Full record

ArticleDrug delivery and translational research2018

Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation.

Maria Natalia Calienni, Carlos Facundo Temprana, Maria Jimena Prieto, Donatella Paolino, Massimo Fresta, Ayse Begum Tekinay, Silvia Del Valle Alonso, Jorge Montanari

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. RSC advances · 2020
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Maria Natalia CalienniLaboratorio de Biomembranas, Departamento de Ciencia y Tecnología, GBEyB. IMBICE, CCT-LA PLATA, CONICET, Universidad Nacional de Quilmes, Bernal, B1876BXD, Buenos Aires, Argentina.
Carlos Facundo TempranaLaboratorio de Inmunología y Virología (LIV), Departamento de Ciencia y Tecnología, CONICET, Universidad Nacional de Quilmes, B1876BXD, Bernal, Argentina.
Maria Jimena PrietoLaboratorio de Biomembranas, Departamento de Ciencia y Tecnología, GBEyB. IMBICE, CCT-LA PLATA, CONICET, Universidad Nacional de Quilmes, Bernal, B1876BXD, Buenos Aires, Argentina.
Donatella PaolinoDepartment of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale S. Venuta, Germaneto, I-88100, Catanzaro, Italy.
Massimo FrestaDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale S. Venuta, Germaneto, I-88100, Catanzaro, Italy.
Ayse Begum TekinayInstitute of Materials Science and Nanotechnology, National Nanotechnology Research Center (UNAM), Bilkent University, 06800, Ankara, Turkey.
Silvia Del Valle AlonsoLaboratorio de Biomembranas, Departamento de Ciencia y Tecnología, GBEyB. IMBICE, CCT-LA PLATA, CONICET, Universidad Nacional de Quilmes, Bernal, B1876BXD, Buenos Aires, Argentina.
Jorge MontanariLaboratorio de Biomembranas, Departamento de Ciencia y Tecnología, GBEyB. IMBICE, CCT-LA PLATA, CONICET, Universidad Nacional de Quilmes, Bernal, B1876BXD, Buenos Aires, Argentina. jmontanari@unq.edu.ar.ORCID http://orcid.org/0000-0002-9177-0240
National University of Quilmes · ARMagna Graecia University · ITBilkent University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the aim of improving the topical delivery of the antineoplastic drug 5-fluorouracil (5FU), it was loaded into ultradeformable liposomes composed of soy phosphatidylcholine and sodium cholate (UDL-5FU). The liposome populations had a mean size of 70 nm without significant changes in 56 days, and the ultradeformable formulations were up to 324-fold more elastic than conventional liposomes. The interaction between 5FU and the liposomal membrane was studied by three methods, and also release profile was obtained. UDL-5FU did penetrate the stratum corneum of human skin. At in vitro experiments, the formulation was more toxic on a human melanoma-derived than on a human keratinocyte-derived cell line. Cells captured liposomes by metabolically active processes. In vivo toxicity experiments were carried out in zebrafish (Danio rerio) larvae by studying the swimming activity, morphological changes, and alterations in the heart rate after incubation. UDL-5FU was more toxic than free 5FU. Therefore, this nano-formulation could be useful for topical application in deep skin precancerous lesions with advantages over current treatments. This is the first work that assessed the induction of apoptosis, skin penetration in a Saarbrücken penetration model, and the toxicological effects in vivo of an ultradeformable 5FU-loaded formulation.

Indexed as

Administration, CutaneousAdministration, TopicalAdultAnimalsAntineoplastic AgentsApoptosisCell LineCell Line, TumorCell SurvivalDrug CompoundingDrug LiberationFemaleFluorouracilHeart RateHumansKeratinocytesAntineoplastic AgentsFluorouracilLiposomesPhosphatidylcholinesSodium Cholate5-FluorouracilSkin therapyTopical deliveryUltradeformable liposomesZebrafish

Identifiers

PMID29288359
OpenAlexW2779010695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.